Ceasing Alpha-blockers Early After Resection of the Prostate (The CLEAR Trial)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 400 participants.
Also called NCT07846579
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 400 participants
- Sponsor
- Registry
-
NCT07846579
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07846579. Randomized; quadruple masking; primary purpose treatment. Start 2026-12-01 (anticipated); primary completion 2028-12-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Ceasing Alpha-blockers Early After Resection of the Prostate (The CLEAR Trial)
- Acronym
- CLEAR
- Condition
- Benign Prostatic Hyperplasia
- Intervention (Drug)
- Tamsulosin hydrochloride 0.2 mg
- Intervention (Drug)
- Placebo
- Lead sponsor
- Shanghai East Hospital
Record details
- Record id
cardio:ct-nct07846579- Content hash
3224d99b2bc7b4e49d7dd533910a912733177a4e570b88f7a2214cdfcdd77af3